Korea Institute of Oriental Medicine

Korea Institute of Ocean Science & Technology

Korea Aerospace Research Institute

Gloria Co., Ltd.

Dong Ho Jung

Jin Sook Kim

Yun Mi Lee

Young Sook Kim

Chan-Sik Kim

Jung Hyun Kim

Junghyun Kim

Eun Jin Shon

Sojin Choi

Seung-Hyun Jung

Bo-Jeong Pyun

Joo Hwan Kim

Jong Min Kim

Ik Soo Lee

Eunjin Shon

Nam-Hee Yoo

Ohn Soon Kim

Hong Gun Sung

Dae Sik Jang

Sa Young Hong

In Bo Park

Suk Kyu Cho

Jun Lee

Jae Sang Jung

Dong Woo Jung

Yong Ju Kwon

Byung Won Park

Chan Sik Kim

Ki Mo Kim

Kyu Hyung Jo

Nan Hee Kim

Joo-Hwan Kim

Bo Woo Nam

Hyeon Ju Kim

Gyu Hyeong Jo

Hyeong Woo Nam

Wang Soo Ryu

Jak Son

Hyun Uk Kwak

JungHyun Kim

Jeong Lim Yoo

A landing apparatus for a reusable launch vehicle is provided, including a landing leg pivotably mounted at one end to the reusable launch vehicle, for example, to a propellant tank part, and mounted at the other end to the propellant tank part by a detaching means such as a pyro bolt for example, a cover mounted to an outside of the landing leg along a longitudinal direction of the landing leg, and a leg landing plate mounted to a distal end of the landing leg and relatively pivotable with respect to the landing leg by its own weight when the other end of the landing leg is separated from the propellant tank part.

Landing apparatus for a reusable launch vehicle

The extract of a mixture of cinnamon twig and moutan root bark, cinnamon twig and peony root, or cinnamon twig and poria according to the present invention has been confirmed to inhibit the excessive generation of advanced glycation end-products, which occurs under chronic diabetic conditions, exhibit the effect of fragmentizing a cross-link between the advanced glycation end-products and matrix proteins, have an excellent effect in inhibiting the generation of the advanced glycation end-products in a human retinal pigment epithelial cell line subjected to a hyperglycemic or aging environment, and have excellent effects in delaying, preventing, and treating diabetic complications, muscular degeneration, commotio retinae, and lower extremity edema in various animal models of diabetic complications, macular degeneration, and lower extremity edema, and thus the mixture extract can effectively be used as an active ingredient for a composition for preventing and treating diabetic complications, including diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy, and angioedema, including macular (retinal) edema, macular degeneration, and varicose veins.

Pharmaceutical composition for preventing or treating diabetic complications and angioedema, containing natural mixture extract as active ingredient

The present invention provides a ship mooring device using a spring bellows structure, wherein the ship mooring device temporarily or permanently fixes a state in which the ship is spaced at a preset distance from a vessel or a pier, the ship mooring device including: a main body configured of a plurality of frames in which opposite ends of each of the frames are hinge-coupled to facing ends of adjacent frames to form foldable hinge joints, wherein diagonally opposed non-adjacent hinge joints of the frames are fixed to the ship and the pier, respectively; and a plurality of wires which are installed inwards in diagonal lines with respect to the frames of the main body to connect the diagonally opposed non-adjacent hinge joints together, with an elastic member interposed in a center portion of the radially disposed wires to generate predetermined dynamic stability when the ship is moved.

Mooring device for vessel using spring bellows structure

The present invention relates to a hydraulic height adjusting device for installing a heavy-weight structure to secure stable horizontal bearing power against a horizontal load of a heavy-weight upper structure. The present invention includes a lower frame which is installed on a top surface of the carrier and is provided with a plurality of receiving portions formed in an upwardly opened shape; and a hydraulic cylinder which is disposed in and engaged to the respective receiving portions of the lower frame, the hydraulic cylinder being moved in a vertical direction to adjust the height of the upper structure, in a state in which an upper end thereof supports the upper structure. The receiving portion is provided with a support guide which is interposed between an inner wall of the receiving portion and the hydraulic cylinder to annually enclose the hydraulic cylinder and thus prevent the hydraulic cylinder from being tilted.

Hydraulic height adjustment device for installing ultra-heavy structure

The present invention relates to a pharmaceutical composition for preventing or treating angioedema, containing as an active ingredient a peony root extract or an extract of a mixture of peony root and licorice. In particular, the extract of a mixture of peony root and licorice according to the present invention inhibits the excessive generation of advanced glycation end products, which may cause macular degeneration, inhibits blood-retinal barrier breakdown causing retinal edema in various animal models, protects or treats a subretinal region causing dry macular degeneration, inhibits angiogenesis causing wet macular degeneration, and thus can be usefully used as an active ingredient for the composition for preventing and treating angioedema including macular degeneration, macular edema, retinal edema, or varicose veins.

Pharmaceutical composition for preventing or treating angioedema, containing extract of peony root or mixture of peony root and licorice as active ingredient

The present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema containing a mixed extract ofleaves andas an active ingredient. More specifically, the present invention relates to a pharmaceutical composition and a health functional food composition for prevention, treatment or amelioration of diabetic complications or angioedema further containing an extract ofleaves,, blueberry, bilberry, raspberry, or grape seeds as an active ingredient, in addition to the mixed extract ofleaves and

Pharmaceutical composition and functional food comprising natural extracts for preventing or treating diabetic complications or angiodema

A floating marine structure which includes a first float disposed at the center and a plurality of second floats disposed around the first float, where the first float has a floating body made of a floatable material in a polygonal prism shape, a damping unit coupled to the bottom of the floating body at the center, having the same cross-section as the floating body, having a cross-sectional area larger than the cross-sectional area of the floating body, and reducing a shake of the first float in the sea, and at least one coupling hole formed at each side of the floating body. The second float has the same shape as the floating body and has coupling protrusions formed at sides facing the sides of the floating body and inserted in the coupling holes, and wherein the coupling holes are formed at alternate sides of the floating body.

Floating marine structure having floats

The present invention relates to a pharmaceutical composition for the prevention and treatment of diabetic complications comprising the extract ofLour. or the fraction thereof as an active ingredient. More particularly, the extract ofLour. or the fractions thereof of the present invention can inhibit the activity of aldose reductase and the generation of the advanced glycation endproducts, the index of diabetic complications, and have powerful activity of inhibiting diabetic complications with brining the anti-cataract, anti-retinopathy, and anti-neuropathy effect, and have the activity of anti-oxidation as well, so that they can be effectively used as an active ingredient of a pharmaceutical composition for the prevention and treatment of diabetic complications.

Pharmaceutical composition for preventing and treating complications of diabetes containing a traditional oriental medicine extract or a fraction thereof as an active ingredient

The present invention provides a novel biphenyl compound or pharmaceutically acceptable salts thereof, methods for preparing the same, and pharmaceutical compositions for preventing or treating diabetic complications containing the same as an active ingredient. Novel biphenyl compounds, according to the present invention, effectively suppress generation activity of advanced glycation end products, which cause diabetic complications and are a criterion for evaluating the effectiveness of a treating agent for diabetic complications, and show an excellent therapeutic effect on retina blood vessels, increased occludin, and decreased angiogenic growth factor in actual diabetic retinopathy induced retina. Thus, novel biphenyl compounds according to the present invention can be used effectively as an active ingredient in compositions for preventing or treating diabetic complications such as diabetic retinopathy.

Biphenyl compound or pharmaceutically acceptable salt thereof, method for preparing novel biphenyl compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient for preventing or treating diabetes complications

The present invention relates to a treatment agent for diabetic complications, and a method for the treatment of diabetic complications using the same. The present invention confirmed thatextract and its fractions inhibited the generation of AGEs, the index for diabetic complications, inhibited the activation of aldose reductase, had anti-cataract activity, and had anti-oxidative activity. Thus, the present invention relates to a preventive and therapeutic agent for diabetic complications containing the saidextract and its fraction as an active ingredient.

[object Object]

Growing community of inventors

Daejeon, South Korea

Dong Ho Jung